<i>NKX2-1</i>mutations leading to surfactant protein promoter dysregulation cause interstitial lung disease in “Brain-Lung-Thyroid Syndrome”
Loïc Guillot(Inserm), Ralph Epaud(Hôpital Intercommunal de Créteil), Gabor Szinnai(University Children’s Hospital Basel), Aurore Carré(Centre National de la Recherche Scientifique), Michel Polak(Hôpital Necker-Enfants Malades), Elodie Tron(Délégation Paris 5), Isabelle Broutin(Centre National de la Recherche Scientifique), Francis Jaubert(Hôpital Necker-Enfants Malades), François Counil(Centre Hospitalier Universitaire de Montpellier), Mireille Castanet(Délégation Paris 5), Delphine Feldmann(Hôpital Armand-Trousseau), Annick Clément(Inserm)
Cited by 130
Related Papers
Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
|The Journal of Experimental Medicine|2010|721
Involvement of Toll-like Receptor 3 in the Immune Response of Lung Epithelial Cells to Double-stranded RNA and Influenza A Virus
|Journal of Biological Chemistry|2004|672
European Society for Paediatric Endocrinology Consensus Guidelines on Screening, Diagnosis, and Management of Congenital Hypothyroidism
|The Journal of Clinical Endocrinology & Metabolism|2014|569
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|562
Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure
|Nature Genetics|2001|538